Literature DB >> 18157629

Omega-3 fatty acids and multiple sclerosis: relationship to depression.

Robin L Aupperle1, Douglas R Denney, Sharon G Lynch, Susan E Carlson, Debra K Sullivan.   

Abstract

Depression is a common problem among patients with multiple sclerosis (MS). Previous research has shown differences between MS patients and controls in the levels of certain fatty acids, and differences in many of these same fatty acids have also been reported in psychiatric patients with major depression. The current study sought to determine whether fatty acid levels in MS patients might be associated with depression. Fatty acids were measured in red blood cells (RBCs) for 38 patients with relapsing-remitting MS and 33 healthy controls who also completed 3-day dietary records and depression questionnaires. Levels of certain omega-3 and omega-6 fatty acids were lower and levels of certain monounsaturated and saturated fatty acids were higher in the MS patients. These differences were generally of medium effect size and occurred despite the fact that no differences were found between the two groups in dietary intake of any fatty acids. However, neither RBC nor dietary fatty acid levels were related to depression in the MS sample.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18157629     DOI: 10.1007/s10865-007-9139-y

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  51 in total

Review 1.  Dietary interventions for multiple sclerosis.

Authors:  M Farinotti; S Simi; C Di Pietrantonj; N McDowell; L Brait; D Lupo; G Filippini
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: phospholipid fatty acids.

Authors:  S E Carlson; R J Cooke; P G Rhodes; J M Peeples; S H Werkman; E A Tolley
Journal:  Pediatr Res       Date:  1991-11       Impact factor: 3.756

Review 3.  Multiple sclerosis and nutrition.

Authors:  Stefan Schwarz; Hans Leweling
Journal:  Mult Scler       Date:  2005-02       Impact factor: 6.312

4.  Psychometric evaluation of the Chicago Multiscale Depression Inventory in multiple sclerosis patients.

Authors:  C-H Chang; D L Nyenhuis; D Cella; T Luchetta; K Dineen; A T Reder
Journal:  Mult Scler       Date:  2003-03       Impact factor: 6.312

5.  Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients.

Authors:  R Edwards; M Peet; J Shay; D Horrobin
Journal:  J Affect Disord       Date:  1998-03       Impact factor: 4.839

Review 6.  Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy.

Authors:  J R Hibbeln; N Salem
Journal:  Am J Clin Nutr       Date:  1995-07       Impact factor: 7.045

7.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

8.  Intake of very-long-chain n-3 fatty acids related to social status and lifestyle.

Authors:  L R Johansson; K Solvoll; G E Bjørneboe; C A Drevon
Journal:  Eur J Clin Nutr       Date:  1998-10       Impact factor: 4.016

9.  Red blood cell fatty acids in multiple sclerosis.

Authors:  X Navarro; R Segura
Journal:  Acta Neurol Scand       Date:  1989-01       Impact factor: 3.209

10.  Mood disorder and multiple sclerosis.

Authors:  R T Joffe; G P Lippert; T A Gray; G Sawa; Z Horvath
Journal:  Arch Neurol       Date:  1987-04
View more
  9 in total

Review 1.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

2.  Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.

Authors:  Insha Zahoor; Yue Li; Ramandeep Rattan; Shailendra Giri
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.

Authors:  Yurika Otoki; Marie Hennebelle; Anthony J Levitt; Kiyotaka Nakagawa; Walter Swardfager; Ameer Y Taha
Journal:  Lipids       Date:  2017-04-24       Impact factor: 1.880

4.  The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.

Authors:  Shima Tavakol; Sahar Shakibapour; Sepideh Arbabi Bidgoli
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

5.  Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids.

Authors:  Joseph R Hibbeln; John M Davis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-07-19       Impact factor: 4.006

6.  The Omega-3 Index Is Inversely Associated with Depressive Symptoms among Individuals with Elevated Oxidative Stress Biomarkers.

Authors:  Sherman J Bigornia; William S Harris; Luis M Falcón; José M Ordovás; Chao-Qiang Lai; Katherine L Tucker
Journal:  J Nutr       Date:  2016-03-02       Impact factor: 4.798

7.  Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis.

Authors:  Laila M Poisson; Hamid Suhail; Jaspreet Singh; Indrani Datta; Aleksandar Denic; Krzysztof Labuzek; Md Nasrul Hoda; Ashray Shankar; Ashok Kumar; Mirela Cerghet; Stanton Elias; Robert P Mohney; Moses Rodriguez; Ramandeep Rattan; Ashutosh K Mangalam; Shailendra Giri
Journal:  J Biol Chem       Date:  2015-11-06       Impact factor: 5.157

Review 8.  The Role of Lipid Biomarkers in Major Depression.

Authors:  Amy Parekh; Demelza Smeeth; Yasmin Milner; Sandrine Thure
Journal:  Healthcare (Basel)       Date:  2017-02-03

Review 9.  An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.

Authors:  Insha Zahoor; Bin Rui; Junaid Khan; Indrani Datta; Shailendra Giri
Journal:  Cell Mol Life Sci       Date:  2021-01-15       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.